Physician
General Surgery
Dr. Asghar Khaghani, MD
|
|
Give Review
Asghar Khaghani works in the field of General Surgery. Doctor Asghar Khaghani, MD is also a published doctor. He has 101 publication published. The most recent publication is: Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome. He is registered with Medicare.
Publications
- Procedural volume and survival after lung transplantation in the United States: the need to look beyond volume in the establishment of quality metrics.
- The effect of pulmonary hypertension on ovine tricuspid annular dynamicsâ€Â
- Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices.
- A novel combination therapy to reverse end-stage heart failure.
- Electron beam tomography for cusp calcification in homograft versus Freestyle xenografts.
- Serum cytokines in left ventricular assist device candidates.
- Long term results of heart transplantation in patients with amyloid heart disease.
- Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts.
- Long-term results after aortic valve replacement in patients with congestive heart failure. Homografts vs prosthetic valves.
- Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation.
- A quantitative study of calcium deposition in the aortic wall following Medtronic Freestyle compared with homograft aortic root replacement. A prospective randomized t...
- Viability in chronic ischaemic cardiomyopathy: need for timely revascularisation.
- Heterotopic heart transplantation through a right thoracotomy.
- Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy.
- Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome.
- Medium term results of lung transplantation for end stage pulmonary sarcoidosis.
- Comparison of neoral and sandimmun cyclosporines for de novo lung transplantation in cystic fibrosis patients.
- Risks and benefits of withdrawing cyclosporine from the long-term immunosuppression regimen of heart and heart-lung transplant recipients.
- Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
- Effects of dipyridamole and adenine/ribose on ATP concentration and adenosine production in cardiac myocytes.
- An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.
- Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry.
- Angiotensin II receptor type 1 mRNA is upregulated in atria of patients with end-stage heart failure.
- Medium term results of direct bronchial arterial revascularisation using IMA for single lung transplantation (SLT with direct revascularisation).
- Heterotopic cardiac transplantation in infants and children.
- Early experience with single lung transplantation for emphysema with simultaneous volume reduction of the contralateral lung.
- Long-term results of heart-lung transplantation for pulmonary hypertension.
- Analysis of 10-year experience with heart-lung transplantation for cystic fibrosis.
- An investigation of the pharmacokinetics, toxicity, and clinical efficacy of Neoral cyclosporin in cystic fibrosis patients.
- Chronic linkage after heterotopic heart transplantation.
- Influence of allograft coronary artery disease on survival and cardiac function in the decade following orthotopic cardiac transplantation.
- Human en bloc double-lung transplantation: bronchial artery revascularization improves airway perfusion.
- Evaluation of the long-term results of single lung versus heart-lung transplantation for emphysema.
- Alternative technique for assessment and repair of the mitral valve.
- Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability.
- The medical management of patients with cystic fibrosis following heart-lung transplantation.
- Retransplantation in heart-lung recipients with obliterative bronchiolitis.
- Successful double-lung transplantation with direct bronchial artery revascularization.
- Congenital cutis laxa with a dominant inheritance and early onset emphysema.
- Coronary artery surgery in women compared with men: analysis of coronary risk factors and in-hospital mortality in a single centre.
- Postoperative hemodynamic improvement with paced linkage of the donor and recipient hearts following heterotopic cardiac transplantation.
- Hemodynamic and metabolic effects of paced linkage following heterotopic cardiac transplantation.
- The effect of cardiopulmonary bypass on gastric and colonic mucosal perfusion: a tonometric assessment.
- Effects of paced counterpulsation on exercise capacity and hemodynamics after heterotopic heart transplantation.
- Wrapping the anastomosis with omentum or an internal mammary artery pedicle does not improve bronchial healing after single lung transplantation: results of a randomiz...
- Heterotopic heart transplantation for elevated pulmonary vascular resistance in pediatric patients.
- [Distant heart procurement in the Czech and Slovak Republics].
- Reoperative aortic valve operation after homograft root replacement: surgical options and results.
- Early experience with the Toronto stentless porcine valve.
- Fourteen-year experience with homovital homografts for aortic valve replacement.
- Microemulsion formulation increases cyclosporin bioavailability in cystic fibrosis.
- Sequential studies of major histocompatibility complex antigen expression (common class I and class II determinants, DR and DQ) in cardiac biopsies following human car...
- Determinants of cyclosporine nephrotoxicity following cardiac transplantation.
- The influence of HLA matching in cardiac allograft recipients receiving cyclosporine and azathioprine.
- Cardiac transplantation at Harefield Hospital.
- Cancer after transplantation.
- Cefotaxime and flucloxacillin as antibiotic prophylaxis in cardiac transplantation.
- Frequency of acute heart and lung rejection after heart-lung transplantation.
- Localisation of atrial natriuretic peptide immunoreactivity in the ventricular myocardium and conduction system of the human fetal and adult heart.
- Raised concentrations of plasma atrial natriuretic peptides in cardiac transplant recipients.
- Heart transplantation for peripartum cardiomyopathy.
- The effect of HLA lymphocytotoxic antibody status and crossmatch result on cardiac transplant survival.
- The influence of HLA matching, donor/recipient sex, and incidence of acute rejection on survival in cardiac allograft recipients receiving cyclosporin A and azathioprine.
- Cardiac transplantation in the seventh decade of life.
- Primary cardiac tumours--is there a place for cardiac transplantation?
- Diastolic function after cardiac and heart-lung transplantation.
- One-stage correction of interrupted aortic arch combined with heart-lung transplantation.
- Distant organ procurement for heart and lung transplantation.
- The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
- Heart-lung transplantation--Harefield experience.
- Factors influencing the development of hypertension after heart transplantation.
- Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation.
- Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study.
- Medium-term results of combined heart and lung transplantation for emphysema.
- Single-lung transplantation for obstructive airway disease.
- Successful retransplantation of the heart and lungs in an adult with cystic fibrosis.
- Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart.
- Gianturco self-expanding metallic stents in treatment of tracheobronchial stenosis after single lung and heart and lung transplantation.
- Heterotopic heart transplantation and recipient heart operation in ischemic heart disease.
- Medium-term results of heart and lung transplantation.
- Normal levels of lipoproteins including lipoprotein(a) after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia.
- Role of the Gianturco expandable metal stent in the management of tracheobronchial obstruction.
- Use of endotracheal silicone stents for relief of tracheobronchial obstruction.
- Intermediate-term results of heart-lung transplantation for cystic fibrosis.
- Determinants of outcome after heterotopic heart transplantation.
- Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calciu...
- Clinical performance with the Levitronix Centrimag short-term ventricular assist device.
- Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery.
- Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome.
- Primary lung carcinoma after heart or lung transplantation: management and outcome.
- Incidence and clinical management of life-threatening left ventricular assist device failure.
- Late donor cardiectomy after paediatric heterotopic cardiac transplantation.
- Current outcome of heart transplantation: a 10-year single centre perspective and review.
- Multicenter evaluation of an intrapericardial left ventricular assist system.
- Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study.
- Echocardiographic assessment of flow across continuous-flow ventricular assist devices at low speeds.
- Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial.
- Sustained myocardial recovery 5 years after in situ disconnection of a Jarvik 2000 device.
- Excision of native heart and relocation of a grown heterotopic donor heart to the orthotopic position 14 years after transplantation.
- European results with a continuous-flow ventricular assist device for advanced heart-failure patients.
Doctors Specialties
- Transplant Surgery
- General Surgery
Accepted Insurances
Drug Facts
| NPI NUMBER | 1760792311 | |
| NPPES Provider LastName | KHAGHANI | |
| NPPES Provider FirstName | ASGHAR | |
| NPPES Provider ZIPCode | 495032556 | |
| NPPES Provider State | MI | |
| Specialty Description | Thoracic Surgery | |
| Total Claim Count | 12.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760792311 |
| Last Name Of The Provider | KHAGHANI |
| First Name Of The Provider | ASGHAR |
| View All |
Similar Doctors
|
|
Dr. Jason D. Slaikeu, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter Wong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Derek T. Nagle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Mitchell, MD |
|
|
Dr. Alexander W. Wilkes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Walters, MD |
|
|
Dr. Gerald P. Wright Jr., MD
This Doctor is OpenDoctor Recommended.
|